Citation

David B. Clifford, David W. Haas, David W. Haas, Heather Ribaudo, Heather Ribaudo, Huan Liu, Matthias Schwab, Elke Schaeffeler, Michel Eichelbaum, Alison A. Motsinger, Marylyn D. Ritchie, Ulrich M. Zanger, Edward P. Acosta, Gene D. Morse, Roy (Trip) Gulick, Gregory K. Robbins. Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS clinical trials group study. Journal of Infectious Diseases. 2010. 202: 717-22. PMID: 20662624

Citation

Keith Crawford, C. Li, A. Keung, Zhaohui Su, Michael Hughes, Wayne Greaves, Daniel R. Kuritzkes, Roy (Trip) Gulick, Charles Flexner. Pharmacokinetic/Pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist vicriviroc in treatment experienced HIV-infected subjects (ACTG protocol 5211). Journal of Acquired Immune Deficiency Syndromes. 2010. 53: 598-605.

Citation

Edgar (Turner) Overton, Minhee Kang, Marion G. Peters, Triin Umbleja, Beverly L. Alston-Smith, Barbara Bastow, Debra DeMarco, Margaret James Koziel, Lori Mong-Kryspin, Heather L. Sprenger, Ji Young Yu, Judith A. Aberg. Immune response to Hepatitis B vaccine in HIV-positive subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG Study 5220. Vaccine. 2010. 28: 5597-604. PMID: 20600512

Citation

Eric S Rosenberg, Barney S. Graham, Ellen Chan, Ronald J. Bosch, Vicki Stocker, Janine Maenza, Martin Markowitz, Susan J. Little, Gary Nabel, Terry L. Flynn, Daniel R. Kuritzkes, Dan H. Barouch. Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection. Public Library of Science One. 2010. 5: e10555. PMID: 20479938

Citation

Nancy Isham, Mahmoud A. Ghannoum. Antifungal activity of miconazole against recent Candida strains. Mycoses. 2010. 53: 434-7. PMID: 19531099

Citation

Robin DiFrancesco, Robin DiFrancesco, Susan L Rosenkranz, Lisa Mukherjee, Lisa M. Demeter, Hongyu Jiang, Robert DiCenzo, Carrie Dykes, Prakash Sista, Alex R. Rinehart, Mary Albrecht, Gene D. Morse. Quality assessment for therapeutic drug monitoring in AIDS clinical trials group (ACTG 5146): a multicenter clinical trial. Therapeutic Drug Monitoring. 2010. 32: 458-66. PMID: 20592644

Citation

Jeffrey T. Schouten, Amy Krambrink, Heather Ribaudo, Anne Kmack, Nancy Webb, Cecilia M. Shikuma, Daniel R. Kuritzkes, Roy (Trip) Gulick. Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095. Clinical Infectious Diseases. 2010. 50: 787-91. PMID: 20121419

Citation

Sonia Napravnik, Ada Cachafeiro, Paul Stewart, Joseph J. Eron, Susan A. Fiscus. HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays. Journal of Clinical Virology. 2010. 47: 18-22. PMID: 19896416

Citation

John Coffin, John W. Mellors, Rajesh Gandhi, Joseph J. Eron, Lu (Summer) Zheng, Ronald J. Bosch, Ellen Chan, David M. Margolis, Sarah W. Read, Beatrice A. Kallungal, Sarah Palmer, Kathleen A. Medvik, Michael M. Lederman, Nadia Alatrakchi, Jeffrey M. Jacobson, A. Wiegand, Mary Kearney. The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial. Public Library of Science: Medicine. 2010. 7: pii: e1000321. PMID: 20711481

Citation

Carrie Dykes, Lisa Mukherjee, Ronald J. Bosch, Elizabeth Connick, Paul Volberding, Lisa M. Demeter. Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371. Journal of Acquired Immune Deficiency Syndromes. 2010. 55: 132-4. PMID: 20733405